Keros Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Keros Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Keros Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $8.79M, a 24.8% increase year-over-year.
  • Keros Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $32.9M, a 48% increase year-over-year.
  • Keros Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $28.8M, a 54% increase from 2022.
  • Keros Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $18.7M, a 59.4% increase from 2021.
  • Keros Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.7M, a 186% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $28.8M +$10.1M +54% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $18.7M +$6.96M +59.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $11.7M +$7.63M +186% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $4.1M +$4.04M +6844% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $59K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.